Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The quest for migraine genes

G M Terwindt1, J Haan, R A Ophoff

  • 1Department of Neurology, Leiden University Medical Centre, The Netherlands.

Current Opinion in Neurology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing migraine care and research through Telemedicine and telemonitoring: E-diary tracking and home EEG.

Computational and structural biotechnology journal·2025
Same author

Quantitative electroencephalography in cerebral amyloid angiopathy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2024
Same author

NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.

Journal of neurology·2024
Same author

Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy.

International journal of stroke : official journal of the International Stroke Society·2024
Same author

Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual-echo arterial spin labeling MRI study.

Headache·2024
Same author

Sex-specific metabolic profiling to explain the increased CVD risk in women with migraine: a narrative review.

The journal of headache and pain·2023
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Researchers identified a specific gene linked to familial hemiplegic migraine. This discovery advances understanding of migraine genetics and aids in developing new treatments.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Migraine genetics research is complex due to polygenic and environmental influences.
  • Familial hemiplegic migraine (FHM) presents a specific subtype for genetic investigation.

Purpose of the Study:

  • To report the discovery of the gene responsible for familial hemiplegic migraine.
  • To explore the implications of this genetic finding for migraine research and treatment.

Main Methods:

  • Genetic linkage analysis and positional cloning were likely employed (details not provided in abstract).

Main Results:

  • Identification of the gene for familial hemiplegic migraine located on chromosome 19p13.
  • This gene encodes a brain-specific P/Q-type calcium channel alpha 1-subunit.

Related Experiment Videos

Conclusions:

  • The identified gene offers a crucial target for understanding migraine pathophysiology.
  • This discovery paves the way for developing targeted prophylactic drugs for migraine.